Herein, about half of the patients with OCLDs have been diagnosed with rheumatic diseases such as SS, RA, AAV, SLE, etc., in which studies have found that moesin may serve as a novel autoantigen [29, 30]. The gene discussed is MSN; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.